# Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

> **NCT02476253** · PHASE3 · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 400 (actual)

## Conditions studied

- Metabolic Acidosis

## Interventions

- **DRUG:** Sodium Bicarbonate

## Key facts

- **NCT ID:** NCT02476253
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-05
- **Primary completion:** 2017-05-29
- **Final completion:** 2017-05-29
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476253, "Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02476253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*